Protocol No.: HLX22-GC-301

A Phase III; Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Principal Investigator
Daboul, Nour
Phase
III
Age Group
Adult
Applicable Disease Site
Gastrointestinal Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Meg Zafiris
Research Specialist

View on ClinicalTrials.gov